Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Decision

Decision

Prioritisation programme

Prioritisation programme

Showing 111 to 120 of 394

TitlePrioritisation programmeDecisionDecision date
Evinacumab for treating homozygous familial hypercholesterolemia in children aged 6 months to 11 [TSID11806]None selectedNot selected
Lomitapide for treating homozygous familial hypercholesterolaemia in people 5 to 17 years [TSID 12085]None selectedNot selected
RenalGuard Therapy for reduction in the incidence of Contrast-Associated AKI (CA-AKI) in at-risk patientsGuidelinesNot prioritised
Human normal immunoglobulin for preventing infection in chronic lymphocytic leukaemia [TSID12043]None selectedNot selected
Henlius (pertuzumab biosimilar) for treating HER2-positive breast cancer [TS ID 12094]None selectedNot selected
Ustekinumab for the treatment of moderately to severely active Crohn's disease in children [TS ID 11955]None selectedn/a
Linaclotide acetate for treating Chronic idiopathic constipation [TSID12005]None selectedNot selected
Sumatriptan–naproxen for treating migraine-related moderate to severe headache [TS ID 12055]None selectedNot selected
Mexiletine hydrochloride for treating myotonia in children and adolescents with myotonic disorders [TS ID 11978]None selectedNot selected
Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic herniaNone selectedFurther information required

Results per page

  1. 10
  2. 25
  3. 50
  4. All